• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains

    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

    Nutrition and Flavor: Formulating for Modern Product Preferences

    What Do Consumers Know About the Gut Microbiome?

    How Will the European Green Deal Impact Dietary Supplements?
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Herbalist and Alchemist Celebrates 40th Anniversary, Announces Expansion

    BASF Venture Capital and Aqua-Spark invest in Sea6 Energy

    Lauren Aronson Joins Amin Talati Wasserman, LLP

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Herbalist and Alchemist Celebrates 40th Anniversary, Announces Expansion

    BASF Venture Capital and Aqua-Spark invest in Sea6 Energy

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Herbalist and Alchemist Celebrates 40th Anniversary, Announces Expansion

    BASF Venture Capital and Aqua-Spark invest in Sea6 Energy

    Lauren Aronson Joins Amin Talati Wasserman, LLP

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    BGG World

    Verdure Sciences

    Botanic Healthcare LLC

    Bioenergy Life Science, Inc. (BLS)

    Nutrition21, LLC
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    BGG World

    Verdure Sciences

    Botanic Healthcare LLC

    Bioenergy Life Science, Inc. (BLS)

    Nutrition21, LLC
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Lonza to Acquire Capsugel for $5.5 Billion

    Deal designed to create leading solutions provider in drug development, formulation, delivery technologies and manufacturing.

    Lonza to Acquire Capsugel for $5.5 Billion
    Related CONTENT
    • Vitafoods Europe 2022 Attendance Returns to 2019 Level
    • Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
    • Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits
    • Lonza Appoints Christian Seufert as President of Capsules, Health Ingredients
    • Lonza’s TWK10 Sports Probiotic Lands in Europe
    12.15.16
    Lonza Group AG, Basel, Switzerland has entered an agreement to acquire Capsugel from the private equity group KKR for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion. The Boards of Directors of both Lonza and Capsugel have approved the transaction.

    The transaction is expected to close in the second quarter of 2017 and is subject to certain regulatory approvals and other customary closing conditions.

    Lonza said the acquisition is in line with its stated strategy to accelerate growth and deliver value along the healthcare continuum by complementing its existing offerings and by opening up new market opportunities in the pharma and consumer healthcare and nutrition industries. With the acquisition of Capsugel, Lonza will add a trusted brand with a large breadth of technologies and will expand the market reach of its contract development and manufacturing organization (CDMO) and products businesses. It will also support Lonza’s strategic ambition of getting closer to the patient and end consumer.

    The acquisition is designed to create a leading integrated, value-added solutions provider in drug development, formulation, delivery technologies and manufacturing for the global pharma and consumer healthcare industries. The combined business will be positioned to benefit from the dynamics in these industries and to anticipate and address technology trends in order to support the evolving needs of its customers, the companies said. It will provide additional value by offering an integrated portfolio of industry-leading technologies, from active pharmaceutical ingredients (APIs) through excipients to dosage forms and delivery technologies.

    Pfizer had previously sold Capsugel to KKR for nearly $2.38 billion in April 2011. Since that time Capsugel acquired a range of companies, including Bend Research Inc., which specializes in bioavailability enhancement, Xcelience, a CDMO, and Powdersize, a contract manufacturer with expertise in particle-size reduction and control technologies, as well as other new dosage technologies.

    Today, with the addition of Capsugel’s oral dosage delivery technologies, including its leading position in hard capsule technologies, Lonza expects to become the partner of choice for its pharma customers along the entire value chain. The combined technologies and offerings will provide customers innovative solutions in both large and small molecules and strengthen Lonza’s ability to support the pharma industry by bringing new, differentiated medicines to market rapidly and efficiently.

    In addition, the acquisition is expected to strengthen Lonza’s position in consumer healthcare and nutrition as Lonza becomes a fully integrated and innovative service provider of active ingredients, oral dosage forms, development services and delivery technologies. As a result, Lonza will be well positioned to meet the increasing need for optimized consumer health and nutrition through a wide offering of next-generation dosage forms. The combined business will also be able to leverage its bioavailability technology to create a new dietary ingredient-ready offering, as well as capitalize on its formulation expertise to develop new ingredients and to market new combination products.

    The enlarged business would have had combined 2015 revenues of approximately CHF 4.8 billion and adjusted EBITDA of approximately CHF 1.1 billion with an enhanced margin profile. Lonza and Capsugel’s highly synergistic customer base and complementary business models will facilitate seamless integration. The combined business will be able to leverage the strong regulatory track record and global footprint of each company.

    With approximately 3,600 employees and 13 facilities on three continents, Capsugel has a customer-centric, entrepreneurial and collaborative culture that aligns with Lonza’s corporate culture. Both companies focus on quality, operational excellence and delivering on promises.

    “The acquisition of Capsugel meets Lonza’s strategic and financial goals,” said Lonza CEO Richard Ridinger. “It accelerates our healthcare continuum strategy by giving us broader exposure to the fast-growing pharma and consumer healthcare markets. We expect the transaction to be accretive to our core earnings per share in the first full year post closing.”

    He explained further, “This new integrated approach will benefit our customers, who will gain from the simplicity and efficiency of working with one company that can provide world-leading support from APIs to excipients and dosage forms. The combined business will allow us to partner with our customers to help them bring highly differentiated products to market more quickly and efficiently.”

    Guido Driesen, president and CEO of Capsugel, said, “This transaction brings together two leading companies that share a common vision—to deliver real value to customers by accelerating their ability to develop and commercialize innovative pharmaceutical and healthcare products. The combination of our complementary technology platforms will put us in a strong position to benefit from evolving trends in the pharma and consumer healthcare markets.”

    He added, “Both companies enjoy a strong quality and regulatory track record, and we believe that the combination enables us to provide the most complete set of tailored and integrated solutions for our customers. We look forward to bringing together our talented teams to deliver science- and engineering-based solutions to customers for the benefit of the patients and consumers who use their products. I am personally committed to making this integration a success.”

    Pete Stavros, member of KKR and head of the Industrials Investing Team, said, “Since acquiring Capsugel five years ago, we have supported Guido and his management team in repositioning the company from a global leader in hard capsules into a specialty CDMO. Capsugel has grown significantly by investing in innovation, strategic acquisitions, product development and geographic expansion. Now Capsugel is well positioned for the next phase of its growth, and we look forward to its continued success as a part of Lonza.”

    Synergies
    The bulk of the benefits resulting from the transaction will be gained from positive top-line and innovation synergies. The highly synergistic customer base, the expanded addressable market and the improved value proposition for the customer will allow Lonza to further leverage its current product and service offerings. Also the acquisition of Capsugel will allow cross-selling of existing products, combine manufacturing solutions and services and create an integrated value offering that merges Lonza’s ingredients with Capsugel’s dosage forms.

    The primary initial focus of this transaction is to ensure a seamless integration while continuing the strong growth trajectory of the Capsugel business. Lonza believes that the step-by-step integration will preserve the strong innovation culture and lead to a combined top-line synergy potential of around CHF 100 million per annum in the mid- to long-term.

    Lonza expects to achieve operating synergies of CHF ~30 million per annum, which are expected to be fully realized by year three, in the areas of corporate, procurement and IT, as well as various efficiency gains. In addition, tax synergies of CHF ~15 million per annum are expected.

    Lonza anticipates that the transaction will be accretive to its CORE Earnings per Share (EPS) from the first full year post closing onwards and intends to retain its current dividend policy.

    Financing and Approvals
    The $5.5 billion all-cash acquisition of Capsugel will be financed with a combination of debt and equity financing. Lonza has committed debt financing for the full acquisition amount from BofA Merrill Lynch and UBS and plans to raise equity, which is fully underwritten by UBS and BofA Merrill Lynch for an amount up to CHF 3.3 billion.

    Lonza’s Board of Directors is currently authorized to increase the share capital through the issuance of 5,000,000 fully paid-in registered shares. Lonza’s Board intends to seek approval for additional share capital at its upcoming annual general meeting (AGM) in April 2017.

    Lonza expects to retain a leverage profile around ~3x net debt/EBITDA at closing and to maintain its unofficial investment-grade credit profile assigned by a number of Swiss banks. Lonza believes that the strong projected cash flow of the combined company will enable rapid de-leveraging after the acquisition and continue to support all planned growth initiatives.

    The financial package foresees the refinancing of Lonza’s current CHF 700 million revolving credit facility.
    Related Searches
    • World Markets
    • Dietary Supplements
    • Mergers & Acquisitions
    • Delivery & Dosage Technologies
    Related Knowledge Center
    • Delivery & Dosage Technologies
    • Mergers & Acquisitions
    • World Markets
    Suggested For You
    Vitafoods Europe 2022 Attendance Returns to 2019 Level Vitafoods Europe 2022 Attendance Returns to 2019 Level
    Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
    Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits
    Lonza Appoints Christian Seufert as President of Capsules, Health Ingredients Lonza Appoints Christian Seufert as President of Capsules, Health Ingredients
    Lonza’s TWK10 Sports Probiotic Lands in Europe Lonza’s TWK10 Sports Probiotic Lands in Europe
    Lonza Capsules & Health Ingredients to Feature Innovative Clean Label Solutions Lonza Capsules & Health Ingredients to Feature Innovative Clean Label Solutions
    OmniActive Names Adam Adelmann Chief Commercial Officer OmniActive Names Adam Adelmann Chief Commercial Officer
    Beauty Ingredient Formulation Directory Fall 2021 Beauty Ingredient Formulation Directory Fall 2021
    Lonza’s Carniking Premix Shown to Improve Protein Turnover and Energy Expenditure in Dogs Lonza’s Carniking Premix Shown to Improve Protein Turnover and Energy Expenditure in Dogs
    Lonza Debuts Non-GMO ‘Made with Organic Collagen’ UC-II in the U.S. Lonza Debuts Non-GMO ‘Made with Organic Collagen’ UC-II in the U.S.
    Oral Solids: Market & Technology Trends Oral Solids: Market & Technology Trends
    Lonza’s DRcaps® Capsules Positioned to Help Usher in Next Generation Formulations Lonza’s DRcaps® Capsules Positioned to Help Usher in Next Generation Formulations
    Lonza Expands Capsule Manufacturing Capacity Lonza Expands Capsule Manufacturing Capacity
    2020 Branded Ingredient Directory 2020 Branded Ingredient Directory
    Sustaining Health ... For People & Planet Sustaining Health ... For People & Planet

    Related Breaking News

    • Breaking News | Consumer Trends | Healthcare Trends | Industry & Market News | World Markets
      Vitafoods Europe 2022 Attendance Returns to 2019 Level

      Vitafoods Europe 2022 Attendance Returns to 2019 Level

      This year's installation of the event brought in over 15,000 participants from 130 countries.
      05.23.22

    • Breaking News | Delivery & Dosage Technologies | Regulations | Supplier News | World Markets
      Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

      Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

      Capsule provides a bright white color while meeting titanium dioxide-free requirements for foods in the EU.
      05.10.22

    • Bone & Joint Health | Breaking News | Proteins, Peptides, Amino Acids | Research News | Sports Nutrition
      Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits

      Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits

      The ingredient, UC-II, showed significant improvements in flexibility and comfort in 96 active, healthy participants.
      04.29.22


    • Breaking News | Contract Manufacturing | Delivery & Dosage Technologies | People News | World Markets
      Lonza Appoints Christian Seufert as President of Capsules, Health Ingredients

      Lonza Appoints Christian Seufert as President of Capsules, Health Ingredients

      Seufert will officially begin his new role on July 1.
      03.23.22

    • Breaking News | Probiotics & Prebiotics | Sports Nutrition | Supplier News | World Markets
      Lonza’s TWK10 Sports Probiotic Lands in Europe

      Lonza’s TWK10 Sports Probiotic Lands in Europe

      Originally sourced from Taiwanese kimchi, L. plantarum probiotic strain addresses athletes' health, performance, and endurance.
      02.17.22

    Loading, Please Wait..
    Trending
    • Omega-3 Fatty Acids Linked To Reduced Episodes Of Depression
    • Oregon Files Lawsuit Against GNC
    • Sesame Oil Cake Extract Improved Memory Among Subjects With Mild Cognitive Impairment
    • Pycnogenol Evidenced To Have Skin Benefits In Dermatology Study
    • Nature’s Way Acquires Personalized Nutrition Company Baze
    Breaking News
    • Herbalist and Alchemist Celebrates 40th Anniversary, Announces Expansion
    • BASF Venture Capital and Aqua-Spark invest in Sea6 Energy
    • Lauren Aronson Joins Amin Talati Wasserman, LLP
    • Vitamin K2 May Ameliorate Polycystic Ovary Syndrome
    • Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • A Growing Herbal Products Market Still Faces Formidable Threats, Challenges
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Nutrition and Flavor: Formulating for Modern Product Preferences
    • Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains
    • How Will the European Green Deal Impact Dietary Supplements?
    • What Do Consumers Know About the Gut Microbiome?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Herbalist and Alchemist Celebrates 40th Anniversary, Announces Expansion
    BASF Venture Capital and Aqua-Spark invest in Sea6 Energy
    Lauren Aronson Joins Amin Talati Wasserman, LLP
    Coatings World

    Latest Breaking News From Coatings World

    Axalta: Red Continues as Most Preferred Car Color of Consumers in Mexico
    Ashland Completes Sale of Land in Ajax, Canada
    Chemours Begins Commissioning New Sand Mine in Clay County, FL
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    M1 MedTech Announces Fall 2022 Cohort
    Preceptis Medical’s Tympanostomy Tube System Cleared for Expanded Indications
    Dyad Medical’s Echocardiogram Application Cleared by FDA
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Grand River Aseptic Manufacturing Completes Phase II Expansion
    WCG Appoints Rahul Bafna Chief Product Officer
    WuXi STA Breaks Ground for New Pharma Mfg. Campus in Middletown, DE
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    SOS Beauty Fills Several Senior Leadership Positions
    Beauty Sales to Higher Income Consumers in U.S. Increase Double-Digits in 2022
    Johnson & Johnson to Discontinue Global Sales of Talc-Based Baby Powder
    Happi

    Latest Breaking News From Happi

    Net Sales Down 5% in Second Quarter Results for Bath & Body Works
    Legacy Skincare Brand Albolene Launches New Line of Facial Cleansers
    Arm & Hammer Laundry Continues Partnership with Dress for Success as Presenting Sponsor of 2022 Virtual Power Walk
    Ink World

    Latest Breaking News From Ink World

    DuPont Selects 2022 Lavoisier and Pedersen Award Medalists
    Chemours Begins Commissioning Newest Sand Mine in Clay County, FL
    Marabu to Present Safe Inks for Indirect Contact with Food at K 2022
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    ePac Flexible Packaging announces global expansion
    Tharstern offering free 3-month trial of new Tharstern Cloud at Labelexpo
    Simco-Ion Industrial expands application engineering expertise
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Because Market Expands into Retail Stores
    Tranzonic Acquired by Private Investment Firm
    Monadnock Earns EcoVadis Gold Rating
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs VySpine's VyPlate Anterior Cervical Plates
    Moximed Raises $40M for Knee OA Shock Absorber Implant
    Exactech Rolls Out Spartan Stem and Logical Cup
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    DuPont Names 2022 Lavoisier and Pedersen Award Medalists
    Photonic Glasses Give Solar Panels Pleasing Colors
    SEMI Appoints John Cooney to Lead Global Advocacy and Public Policy

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login